A model for improving coverage policy decisions

American Journal of Managed Care

Volumn 5, Issue 8 SUPPL., 1999, Pages 981-991

  Priester, Reinhard ^a,b   Gervais, Karen G ^a   Vawter, Dorothy E ^a  

^a Minnesota Center for Health Care Ethics   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; DECISION MAKING; DISASTER; ECONOMICS; HEALTH CARE ORGANIZATION; HUMAN; INSURANCE; METHODOLOGY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; POLICY; SOCIAL JUSTICE; UNITED STATES;

DECISION MAKING; EFFICIENCY, ORGANIZATIONAL; ELIGIBILITY DETERMINATION; HEALTH CARE RATIONING; HUMANS; INSURANCE COVERAGE; MODELS, ORGANIZATIONAL; ORGANIZATIONAL POLICY; RESCUE WORK; SOCIAL JUSTICE; UNITED STATES;

EID: 0033175868     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Eddy DM. Benefit language: Criteria that will improve quality while reducing costs. JAMA 1996;275:650-657.
2. James FP. The experimental treatment exclusion clause: A tool for silent rationing of health care? J Legal Med 1991;12:359-418.
3. Steinberg E, Tunis S, Shapiro D. Insurance coverage for experimental technologies. Health Aff 1995;14(4):143-158.
4. Newcomer LN. Defining experimental therapy-a thirdparty payer's dilemma. N Eng!) Med 1990;323:1702-1704.
5. Cova IL. A swift response to a modest proposal. J Nail Cancer /nsM992;84:744- 745.
6. Braslow NM, Shatin D, McCarthy DB, et al. Role of technology assessment in health benefits coverage for medical devices. Am) Manag Care 1998;4(special issue):SP139- SP150.
7. Morreim EH. Balancing Act: The New Medical Ethics of Medicine's New Economics. Dordrecht, Netherlands: Kluwer Academic Publishers; 1991.
8. Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. JAMA 1996;276:1172-1177.
9. Reinhardt UE. Making economic evaluations respectable. Soc Sci Med 1997;45:555-562.
10. Physician Payment Review Commission (PPRC). Coverage decisions and technology assessment. In: PPRC Annual Report to Congress. Washington, DC: Physician Payment Review Commission; 1994:231.
11. Gleeson S. Blue Cross and Blue Shield association initiatives in technology assessment. In: Gelijns A, Dawkins HV, eds. Adopting New Medical Technology, vol IV. Washington, DC: National Academy Press; 1994.
12. Fuchs VR, Garber AM. The new technology assessment. N Eng!) Med 1990;323:673- 677.
13. Garber AM, Owens D. Paying for evaluative research. In: Gelijns A, Dawkins HV, eds. Adopting New Medical Technology, vol IV. Washington, DC: National Academy Press; 1994.
14. Brock DW, Daniels N. Ethical foundations of the Clinton administration's proposed health care system. JAMA 1994;271:1189-1196.
15. Hadorn DC. Setting health care priorities in Oregon: Costeffectiveness meets the rule of rescue. JAMA 1991;265:2218-2225.
16. Jonsen AR. Bentham in a box: Technology assessment and health care allocation. Law Med Health Care 1986;14(34):172-174.
17. Lairson P. Kaiser Permanente's new technology committee: Coverage decisionmaking in a group model health maintenance organization. In: Gelijns A, Dawkins HV, eds. Adopting New Medical Technology, vol IV. Washington, DC: National Academy Press; 1994.
18. Emanuel EJ, Emanuel LL. What is accountability in health care? Ann Intern Med 1996;124:229-239.
19. Fleck LM. Just health care rationing: A democratic decisionmaking approach. U Penn Law 1992;140:1597-1636.
20. Havighurst CC. Prospective self-denial: Can consumers contract today to accept health care rationing tomorrow? U Penn Law 1992;140:1755-1808.
21. Office of Technology Assessment. Evaluation of the Oregon Medicaid Proposal. Washington, DC: US Government Printing Office; 1992.
22. Priester R, Gervais KG. A Role Playing Exercise in Managed Care Decision Making: Coverage for Experimental ' Interventions-An Instructional Guide. Minneapolis, MN: Minnesota Center for Health Care Ethics; 1999.
23. Kuttner R. The risk-adjustment debate. N Engl J Med 1998;339:1952-1956.
24. Daniels N, Sabin JE. Last chance therapies and managed care: Pluralism, fair procedures, and legitimacy. Hastings Cent Kep1998;28:27-41.
25. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-25.